<DOC>
	<DOCNO>NCT00209014</DOCNO>
	<brief_summary>Patients relapse refractory large B-cell lymphoma ask take part study . The purpose study find effect ( good bad ) drug thalidomide patient lymphoma .</brief_summary>
	<brief_title>Phase II Trial Thalidomide Refractory/Relapsed Diffuse Large B-Cell Lymphoma Hodgkin 's Disease</brief_title>
	<detailed_description>Patients relapse refractory large B-cell lymphoma ask take part study . This research do current treatment help everyone disease . The purpose study find effect ( good bad ) drug thalidomide patient lymphoma . Thalidomide show activity cancer approve FDA treatment lymphoma . Thalidomide prevents growth new blood vessel allow cancer cell receive nourishment spread . Another reason study researcher want learn drug work whether patient respond good others .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , B-Cell</mesh_term>
	<mesh_term>Lymphoma , Large B-Cell , Diffuse</mesh_term>
	<mesh_term>Hodgkin Disease</mesh_term>
	<mesh_term>Thalidomide</mesh_term>
	<criteria>Patients expect survival period 6 month great diagnose stage diffuse large Bcell lymphoma Hodgkin 's disease eligible participate study . Final eligibility determine health professional conduct trial . Women pregnant , lactate refuse pregnancy test eligible study . Also , patient active infection , history current previous deep vein thrombosis and/or currently receive anticoagulant therapy deep vein thrombosis exclude participation study . Final eligibility determine health professional conduct trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>B-Cell Lymphoma</keyword>
	<keyword>Hodgkin 's Disease</keyword>
</DOC>